Elranatamab achieves a lasting response in 61% of patients with multiple myeloma and complete remission in 30%, one expert observed.
and complete remission in 30%," said Dr María Victoria Mateos, a consultant physician in the Hematology Service at the University Clinical Hospital of Salamanca, Spain , and president of the Spanish Society of Haematology and Haemotherapy.
Although most patients will eventually exhaust the treatments, which until now were primarily triple-drug regimens , the introduction of new therapies is extending the duration of responses.It is very high, in the sense that almost all patients with multiple myeloma eventually relapse. However, we hope that there soon will be some patients who do not relapse.
This medication has been approved for patients with relapsed myeloma who have received traditional drugs for their treatment. We know well that patients who have already received proteasome inhibitors, immunomodulators, and anti-CD38 antibodies typically need something new after treatment. Before, there were no other options, and we would reuse what had been previously used.
The second most common adverse event we need to be cautious about is infection. Nowadays, before starting treatment, patients update their vaccination schedule, receive antiviral prophylaxis, and receive prophylaxis against certain germs, resulting in reduced infections. However, infections are probably the adverse events we need to be most careful about when treating the patient.
With the already approved elranatamab, the most important aspect is that it adds another treatment option for patients with myeloma. With the progression-free survival data I indicated, life expectancy is increased, with a good quality of life and acceptable safety.
Myeloma Plasma Cell Myeloma Targeted Therapy Targeted Cancer Therapy Medical Innovations Innovations In Medicine Innovation Refractory Remission Cancer Malignant Neoplasia Carcinoma Malignant Neoplasm Tumor Spain Spanish Leukemia Leukaemia Blood Cancer Biologic Therapy Biologics Fellowship Fellows Residency Residents Healthcare And Medical Technology
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Blood test may guide use of multiple myeloma immunotherapyA simple blood test that measures the number of lymphocytes, a type of white blood cell in the body, may predict whether people who have relapsed multiple myeloma are going to respond well to CAR-T immunotherapy, according to new research.
Read more »
Multiple motorists rescued from flooded roadways in New Jersey and New YorkMultiple motorists stranded on flooded roadways in New York and New Jersey had to be rescued Tuesday night as some parts of the region got six inches of rain.
Read more »
Multiple failures, multiple investigations: Unraveling the attempted assassination of Donald TrumpMultiple investigations have been launched into the attempted assassination of Donald Trump.
Read more »
Multiple failures, multiple investigations: Unraveling the attempted assassination of Donald TrumpMultiple investigations have been launched into the attempted assassination of Donald Trump.
Read more »
Multiple failures, multiple investigations: Unraveling the attempted assassination of Donald TrumpMultiple investigations have been launched into the attempted assassination of Donald Trump.
Read more »
Multiple failures, multiple investigations: Unraveling the attempted assassination of Donald TrumpBUTLER, Pa. (AP) — The young man was pacing around the edges of the Donald Trump campaign rally, shouldering a big backpack and peering into the lens of a
Read more »